Sfoglia per Autore
Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients
2018-01-01 Gagliardi, Stella*; Zucca, Susanna; Pandini, Cecilia; Diamanti, Luca; Bordoni, Matteo; Sproviero, Daisy; Arigoni, Maddalena; Olivero, Martina; Pansarasa, Orietta; Ceroni, Mauro; Calogero, Raffaele; Cereda, Cristina
Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF
2017-01-01 Konda, John D.; Olivero, Martina; Musiani, Daniele; Lamba, Simona; Di Renzo, Maria F.
Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism
2016-01-01 Torchiaro, Erica; Lorenzato, Annalisa; Olivero, Martina; Valdembri, Donatella; Gagliardi, Paolo Armando; Gai, Marta; Erriquez, Jessica; Serini, Guido; Di Renzo, Maria Flavia
The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs
2016-01-01 Lorenzato, Annalisa; Torchiaro, Erica; Olivero, Martina; Di Renzo, Maria Flavia
TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin. TOP2A as marker of response to PLD in ovarian cancer
2015-01-01 Erriquez, J.; Becco, P.; Olivero, M.; Ponzone, R.; Maggiorotto, F.; Ferrero, A.; Scalzo, M.S.; Canuto, E.M.; Sapino, A.; Verdun di Cantogno, L.; Bruna, P.; Aglietta, M.; Di Renzo, M.F.; Valabrega, G.
The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase.
2014-01-01 Olivero M;Dettori D;Arena S;Zecchin D;Lantelme E;Di Renzo MF
PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy
2014-01-01 Musiani, Daniele; Hammond, Dean E.; Cirillo, Luca; Erriquez, Jessica; Olivero, Martina; Clague, Michael J.; Di Renzo, Maria Flavia
Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy.
2014-01-01 Musiani, Daniele; Konda, John David; Pavan, Simona; Torchiaro, Erica; Sassi, Francesco; Noghero, Alessio; Erriquez, Jessica; Perera, Timothy; Olivero, Martina; Di Renzo, Maria Flavia
HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor.
2014-01-01 Pavan S;Musiani D;Torchiaro E;Migliardi G;Gai M;Di Cunto F;Erriquez J;Olivero M;Di Renzo MF
AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.
2013-01-01 Lorenzato A;Biolatti M;Delogu G;Capobianco G;Farace C;Dessole S;Cossu A;Tanda F;Madeddu R;Olivero M;Di Renzo MF
IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
2013-01-01 Pavan S;Olivero M;Corà D;Di Renzo MF
The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C
2012-01-01 Lorenzato A; Martino C; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Olivero M; Di Renzo MF.
The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors
2012-01-01 Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patanè S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
Cells lacking the fumarase tumor suppressor are protected from apoptosis through a HIF-independent, AMPK dependent mechanism.
2012-01-01 Bardella C;Olivero M;Lorenzato A;Geuna M;Adam J;O'Flaherty L;Rustin P;Tomlinson I;Pollard PJ;Di Renzo MF
Inhibition of P90RSK Sensitizes Ovarian Cancer Cells to Apoptosis
2012-01-01 Torchiaro E ; Olivero M ; Pavan S ; Di Renzo MF
HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel
2012-01-01 Pavan S ; Musiani D ; Torchiaro E ; Migliardi G ; Olivero M; Di Renzo MF
DNA damage stress phenotype makes cancer cells addicted to a redundant CUL4 dependent pathway
2011-01-01 Olivero M; Dettori D; Pavan S; Di Renzo MF
The cellular apoptosis susceptibility CAS/CSE1L gene specifically protects ovarian cancer cells from death by suppressing RASSF1C
2011-01-01 Lorenzato A; Martino C; Olivero M; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Di Renzo MF
The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors
2011-01-01 Dani N; Olivero M; Mareschi K; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
MET-ONCOGENE TRANSFORMS HUMAN PRIMARY BONE-DERIVED CELLS BY TARGETING OSTEOPROGENITORS
2010-01-01 N Dani; M Olivero; S Patane; M VanDuist; K Mareschi(1); F Fagioli(1); Di Renzo MF
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients | 2018 | Gagliardi, Stella*; Zucca, Susanna; Pandini, Cecilia; Diamanti, Luca; Bordoni, Matteo; Sproviero, Daisy; Arigoni, Maddalena; Olivero, Martina; Pansarasa, Orietta; Ceroni, Mauro; Calogero, Raffaele; Cereda, Cristina | |
| Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF | 2017 | Konda, John D.; Olivero, Martina; Musiani, Daniele; Lamba, Simona; Di Renzo, Maria F. | |
| Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism | 2016 | Torchiaro, Erica; Lorenzato, Annalisa; Olivero, Martina; Valdembri, Donatella; Gagliardi, Paolo Armando; Gai, Marta; Erriquez, Jessica; Serini, Guido; Di Renzo, Maria Flavia | |
| The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs | 2016 | Lorenzato, Annalisa; Torchiaro, Erica; Olivero, Martina; Di Renzo, Maria Flavia | |
| TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin. TOP2A as marker of response to PLD in ovarian cancer | 2015 | Erriquez, J.; Becco, P.; Olivero, M.; Ponzone, R.; Maggiorotto, F.; Ferrero, A.; Scalzo, M.S.; Canuto, E.M.; Sapino, A.; Verdun di Cantogno, L.; Bruna, P.; Aglietta, M.; Di Renzo, M.F.; Valabrega, G. | |
| The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase. | 2014 | Olivero M;Dettori D;Arena S;Zecchin D;Lantelme E;Di Renzo MF | |
| PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy | 2014 | Musiani, Daniele; Hammond, Dean E.; Cirillo, Luca; Erriquez, Jessica; Olivero, Martina; Clague, Michael J.; Di Renzo, Maria Flavia | |
| Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy. | 2014 | Musiani, Daniele; Konda, John David; Pavan, Simona; Torchiaro, Erica; Sassi, Francesco; Noghero, Alessio; Erriquez, Jessica; Perera, Timothy; Olivero, Martina; Di Renzo, Maria Flavia | |
| HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor. | 2014 | Pavan S;Musiani D;Torchiaro E;Migliardi G;Gai M;Di Cunto F;Erriquez J;Olivero M;Di Renzo MF | |
| AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells. | 2013 | Lorenzato A;Biolatti M;Delogu G;Capobianco G;Farace C;Dessole S;Cossu A;Tanda F;Madeddu R;Olivero M;Di Renzo MF | |
| IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness. | 2013 | Pavan S;Olivero M;Corà D;Di Renzo MF | |
| The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C | 2012 | Lorenzato A; Martino C; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Olivero M; Di Renzo MF. | |
| The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors | 2012 | Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patanè S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF | |
| Cells lacking the fumarase tumor suppressor are protected from apoptosis through a HIF-independent, AMPK dependent mechanism. | 2012 | Bardella C;Olivero M;Lorenzato A;Geuna M;Adam J;O'Flaherty L;Rustin P;Tomlinson I;Pollard PJ;Di Renzo MF | |
| Inhibition of P90RSK Sensitizes Ovarian Cancer Cells to Apoptosis | 2012 | Torchiaro E ; Olivero M ; Pavan S ; Di Renzo MF | |
| HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel | 2012 | Pavan S ; Musiani D ; Torchiaro E ; Migliardi G ; Olivero M; Di Renzo MF | |
| DNA damage stress phenotype makes cancer cells addicted to a redundant CUL4 dependent pathway | 2011 | Olivero M; Dettori D; Pavan S; Di Renzo MF | |
| The cellular apoptosis susceptibility CAS/CSE1L gene specifically protects ovarian cancer cells from death by suppressing RASSF1C | 2011 | Lorenzato A; Martino C; Olivero M; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Di Renzo MF | |
| The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors | 2011 | Dani N; Olivero M; Mareschi K; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF | |
| MET-ONCOGENE TRANSFORMS HUMAN PRIMARY BONE-DERIVED CELLS BY TARGETING OSTEOPROGENITORS | 2010 | N Dani; M Olivero; S Patane; M VanDuist; K Mareschi(1); F Fagioli(1); Di Renzo MF |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile